• THE pharmaceutical movement has struggled to overcome the challenges of the Covid-19 pandemic and, by and large, they have triumphed.

There remains, however, one area in which work needs to be done. This concerns the extent to which staff need to improve their conversations with members of the public.

I recently attended a chemist who had done a prescription for me and asked to speak to the pharmacist, in line with the government’s diktat to reduce pressure on GP surgeries.

I was concerned over contraindications of two pieces of medication I had been prescribed. The member of staff went into the pharmacy and came out two minutes later to say, “They’re on the phone”.

That is, not, “I’m sorry, the pharmacist is busy; please take a seat, they will see you in a minute or two.” Or “I am sorry, the pharmacist is busy. Could you ring 111?”.

I was able to find answers elsewhere but just imagine if I was elderly, disabled, depressed, or a foreigner. And just imagine if the contraindication had been important and had resulted in a new health issue.

I think there is something of a duty of care. I also think that it is a pity that excellent service by so many can be spoilt by a small minority.

CHRISTOPHER MASON
Address supplied